| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K55473186 |
| PharmacoGx | BRD-K55473186 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC9C1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | RTN2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | GTSF1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PRDM16 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | CTD-3105H18.16 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PRIMA1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | CACNG5 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | P2RY8 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | DBP | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
